{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,24]],"date-time":"2026-02-24T10:41:47Z","timestamp":1771929707592,"version":"3.50.1"},"reference-count":36,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2017,5,1]],"date-time":"2017-05-01T00:00:00Z","timestamp":1493596800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,5,1]],"date-time":"2017-05-01T00:00:00Z","timestamp":1493596800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jfas.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Foot and Ankle Surgery"],"published-print":{"date-parts":[[2017,5]]},"DOI":"10.1053\/j.jfas.2017.01.014","type":"journal-article","created":{"date-parts":[[2017,3,22]],"date-time":"2017-03-22T02:06:13Z","timestamp":1490148373000},"page":"484-491","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":22,"title":["Procalcitonin as a Biomarker for Predicting Amputation Level in Lower Extremity Infections"],"prefix":"10.1053","volume":"56","author":[{"given":"Matthew M.","family":"Reiner","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wissam E.","family":"Khoury","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael B.","family":"Canales","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Richard A.","family":"Chmielewski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kartick","family":"Patel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mark C.","family":"Razzante","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Coleman O.","family":"Cloughtery","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Douglas Y.","family":"Rowland","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1053\/j.jfas.2017.01.014_bib1","unstructured":"Centers for Disease Control and Prevention. 2014 National Diabetes Statistics Report. Available at: https:\/\/www.cdc.gov\/diabetes\/data\/statistics\/2014StatisticsReport.html. Accessed October 28,\u00a02014."},{"key":"10.1053\/j.jfas.2017.01.014_bib2","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1001\/jama.293.2.217","article-title":"Preventing foot ulcers in patients with diabetes","volume":"293","author":"Singh","year":"2005","journal-title":"JAMA"},{"key":"10.1053\/j.jfas.2017.01.014_bib3","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1007\/BF02596446","article-title":"A controlled trial to increase office visits and reduce hospitalization in diabetic patients","volume":"2","author":"Smith","year":"1987","journal-title":"J General Int Med"},{"key":"10.1053\/j.jfas.2017.01.014_bib4","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1177\/1534734603002001002","article-title":"Changing perspectives in diabetic foot ulcer management","volume":"2","author":"Dang","year":"2003","journal-title":"Int J Low Extrem Wounds"},{"key":"10.1053\/j.jfas.2017.01.014_bib5","doi-asserted-by":"crossref","first-page":"2021","DOI":"10.2337\/dc12-0200","article-title":"Long-term prognosis of diabetic foot patients and their limbs: amputation and death over the course of a decade","volume":"35","author":"Morbach","year":"2012","journal-title":"Diabetes Care"},{"key":"10.1053\/j.jfas.2017.01.014_bib6","doi-asserted-by":"crossref","first-page":"2129","DOI":"10.2337\/diacare.27.9.2129","article-title":"Costs of lower extremity ulcers among patients with diabetes","volume":"27","author":"Stockl","year":"2004","journal-title":"Diabetes Care"},{"key":"10.1053\/j.jfas.2017.01.014_bib7","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1177\/1071100713483116","article-title":"Cost comparison: limb salvage versus amputation in diabetic patients with Charcot foot","volume":"34","author":"Gil","year":"2003","journal-title":"Foot Ankle Int"},{"key":"10.1053\/j.jfas.2017.01.014_bib8","first-page":"143","article-title":"Transcutaneous oximetry in clinical practice: consensus statements from an expert based panel","volume":"36","author":"Fife","year":"2009","journal-title":"Undersea Hyperb Med"},{"key":"10.1053\/j.jfas.2017.01.014_bib9","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.ejvs.2011.12.004","article-title":"The use of transcutaneous oximetry to predict healing complications of lower limb amputations: a systemic review and meta-analysis","volume":"43","author":"Arsenault","year":"2012","journal-title":"Eur J Vasc Endovasc Surg"},{"key":"10.1053\/j.jfas.2017.01.014_bib10","doi-asserted-by":"crossref","first-page":"203","DOI":"10.2106\/00004623-198870020-00007","article-title":"Transcutaneous oxygen tension as a predictor of success after an amputation","volume":"70","author":"Wyss","year":"1988","journal-title":"J Bone Joint Surg"},{"key":"10.1053\/j.jfas.2017.01.014_bib11","doi-asserted-by":"crossref","first-page":"70","DOI":"10.4103\/0970-9185.92444","article-title":"Evaluation of the efficacy of hyperbaric oxygen therapy in the management of chronic nonhealing ulcer and role of periwound transcutaneous oximetry as a predictor of wound healing response: a randomized prospective controlled trial","volume":"28","author":"Kaur","year":"2012","journal-title":"J Anaesthesiol Clin Pharmacol"},{"key":"10.1053\/j.jfas.2017.01.014_bib12","series-title":"Syme\u2019s Amputation: A Retrospective Review of 10 Cases","author":"Yu","year":"2005"},{"key":"10.1053\/j.jfas.2017.01.014_bib13","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.2106\/00004623-198668070-00013","article-title":"Amputations at the middle level of the foot, retrospective and prospective review","volume":"68","author":"Pinzur","year":"1986","journal-title":"J Bone Joint Surg"},{"key":"10.1053\/j.jfas.2017.01.014_bib14","first-page":"263","article-title":"Procalcitonin: experience with a new diagnostic tool for bacterial infection and systemic inflammation","volume":"23","author":"Meisner","year":"1999","journal-title":"J Lab Med"},{"key":"10.1053\/j.jfas.2017.01.014_bib15","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1007\/s001340050683","article-title":"Kinetics of procalcitonin in iatrogenic sepsis","volume":"24","author":"Brunkhorst","year":"1998","journal-title":"Intens Care Med"},{"key":"10.1053\/j.jfas.2017.01.014_bib16","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1164\/ajrccm.164.3.2009052","article-title":"Diagnostic value of procalcitonin, interleukin-6, and interleukin-8 in critically ill patients admitted with suspected sepsis","volume":"164","author":"Harbarth","year":"2001","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1053\/j.jfas.2017.01.014_bib17","doi-asserted-by":"crossref","first-page":"R291","DOI":"10.1186\/cc13157","article-title":"Procalcitonin-guided therapy in intensive care unit patients with severe sepsis and septic shock\u2014a systematic review and meta-analysis","volume":"17","author":"Prkno","year":"2013","journal-title":"Crit Care"},{"key":"10.1053\/j.jfas.2017.01.014_bib18","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pone.0065564","article-title":"Changes in circulating procalcitonin versus C-reactive protein in predicting evolution of infectious disease in febrile, critically ill patients","volume":"8","author":"Hoeboer","year":"2013","journal-title":"PLos One"},{"key":"10.1053\/j.jfas.2017.01.014_bib19","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1007\/s001340051144","article-title":"Procalcitonin for discrimination between activity of systemic autoimmune disease and systemic bacterial infection","volume":"26","author":"Brunkhorst","year":"2000","journal-title":"Intens Care Med"},{"key":"10.1053\/j.jfas.2017.01.014_bib20","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1016\/j.ajem.2013.12.035","article-title":"Prediction of blood culture results by measuring procalcitonin levels and other inflammatory biomarkers","volume":"32","author":"Arai","year":"2013","journal-title":"Am J Emerg Med"},{"key":"10.1053\/j.jfas.2017.01.014_bib21","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.2169\/internalmedicine.53.1785","article-title":"Clinical utility of procalcitonin as a marker of sepsis: a potential predictor of causative pathogens","volume":"53","author":"Nakajima","year":"2014","journal-title":"Intern Med"},{"key":"10.1053\/j.jfas.2017.01.014_bib22","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.jdiacomp.2012.03.018","article-title":"Does treatment affect the levels of serum interleukin-6, interleukin-8 and procalcitonin in diabetic foot infection? A pilot study","volume":"26","author":"Altay","year":"2012","journal-title":"J Diabetes Complications"},{"key":"10.1053\/j.jfas.2017.01.014_bib23","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1016\/j.amjsurg.2012.11.024","article-title":"Procalcitonin ratio as a predictor of successful surgical treatment of severe necrotizing soft tissue infections","volume":"206","author":"Friederichs","year":"2013","journal-title":"Am J Surg"},{"key":"10.1053\/j.jfas.2017.01.014_bib24","first-page":"1","article-title":"Procalcitonin clearance for early prediction for survival in critically ill patients with severe sepsis","volume":"2014","author":"Nor","year":"2014","journal-title":"Crit Care Res Pract"},{"key":"10.1053\/j.jfas.2017.01.014_bib25","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1093\/ndt\/gfs339","article-title":"Diagnostic value of serum procalcitonin in patients with chronic renal insufficiency: a systematic review and meta-analysis","volume":"28","author":"Lu","year":"2013","journal-title":"Nephrol Dial Transplant"},{"key":"10.1053\/j.jfas.2017.01.014_bib26","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1097\/00003643-200102000-00004","article-title":"The plasma elimination and urinary secretion of procalcitonin in patients with normal and impaired renal function","volume":"18","author":"Meisner","year":"2001","journal-title":"Eur J Anaesthesiol"},{"key":"10.1053\/j.jfas.2017.01.014_bib27","article-title":"Procalcitonin: contributing to improved clinical decision making","volume":"23","author":"Barnes","year":"2013","journal-title":"ThermoFisher Scientific Lecture"},{"key":"10.1053\/j.jfas.2017.01.014_bib28","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1620\/tjem.213.305","article-title":"Procalcitonin as a diagnostic aid in diabetic foot infections","volume":"213","author":"Uzun","year":"2007","journal-title":"Tohoku J Exp Med"},{"key":"10.1053\/j.jfas.2017.01.014_bib29","first-page":"e133376","article-title":"Can procalcitonin be an accurate diagnostic marker for the classification of diabetic foot ulcers?","volume":"12","author":"Jafari","year":"2014","journal-title":"Int J Endocrinol Metab"},{"key":"10.1053\/j.jfas.2017.01.014_bib30","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.diabres.2011.05.023","article-title":"Can procalcitonin predict bone infection in people with diabetes with infected foot ulcers? A pilot study","volume":"94","author":"Mutluoglu","year":"2011","journal-title":"Diabetes Res Clin Pract"},{"key":"10.1053\/j.jfas.2017.01.014_bib31","first-page":"578","article-title":"Predictive value of soluble CD14, interleukin-6 and procalcitonin for lower extremity amputation in people with diabetes with foot ulcers: a pilot study","volume":"30","author":"Karakas","year":"2014","journal-title":"Pak J Med Sci"},{"key":"10.1053\/j.jfas.2017.01.014_bib32","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1177\/145749691210100211","article-title":"End-stage renal disease and critical limb ischemia: a deadly combination?","volume":"101","author":"Biancari","year":"2012","journal-title":"Scand J Surg"},{"key":"10.1053\/j.jfas.2017.01.014_bib33","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1016\/S0891-5520(05)70179-3","article-title":"Saving the diabetic foot with special references to the patient with chronic renal failure","volume":"15","author":"Deery","year":"2001","journal-title":"Infect Dis Clin North Am"},{"key":"10.1053\/j.jfas.2017.01.014_bib34","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1001\/archsurg.1988.01400330144022","article-title":"Limb salvage in end-stage renal disease (ESRD): comparison of modern results in patients with and without ESRD","volume":"123","author":"Edwards","year":"1988","journal-title":"Arch Surg"},{"key":"10.1053\/j.jfas.2017.01.014_bib35","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.diabres.2016.04.030","article-title":"Long term outcomes of diabetic haemodialysis patients with critical limb ischemia and foot ulcer","volume":"116","author":"Meloni","year":"2016","journal-title":"Diabetes Res Clin Pract"},{"key":"10.1053\/j.jfas.2017.01.014_bib36","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1097\/01.CCM.0000129486.35458.7D","article-title":"The LRINEC (Laboratory Risk Indicator for Necrotizing Fasciitis) score: a tool for distinguishing necrotizing fasciitis from other soft tissue infections","volume":"32","author":"Wong","year":"2004","journal-title":"Crit Care Med"}],"container-title":["The Journal of Foot and Ankle Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1067251617300145?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1067251617300145?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T05:03:08Z","timestamp":1761022988000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1067251617300145"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,5]]},"references-count":36,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2017,5]]}},"alternative-id":["S1067251617300145"],"URL":"https:\/\/doi.org\/10.1053\/j.jfas.2017.01.014","relation":{},"ISSN":["1067-2516"],"issn-type":[{"value":"1067-2516","type":"print"}],"subject":[],"published":{"date-parts":[[2017,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Procalcitonin as a Biomarker for Predicting Amputation Level in Lower Extremity Infections","name":"articletitle","label":"Article Title"},{"value":"The Journal of Foot and Ankle Surgery","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1053\/j.jfas.2017.01.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 by the American College of Foot and Ankle Surgeons. All rights reserved.","name":"copyright","label":"Copyright"}]}}